After months of deliberation, and no formal offers from a buyer, Novartis has decided that its generics business Sandoz will be spun out into an independent company. The Swiss pharma group said ...
A Aaaaaaa Aaa 26.05 +27.74% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback